Skip to content

News

Super Saturday Events Raise Close to $3.5 Million for OCRFA

Super Saturday Events Raise Close to $3.5 Million for OCRFA

  Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins, Star Jones, Congresswoman Carolyn Maloney, Rebecca Minkoff, Cathy Moriarty-Gentile, Elin Nordegren, Molly Sims, … Continued

Impact of Genetic Counseling on Testing and Surgical Preven...

Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women

(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, … Continued

Women Still Getting CA-125 and CT Testing After Ovarian Can...

Women Still Getting CA-125 and CT Testing After Ovarian Cancer, Despite Lack of Clear Benefit

(July 28, 2016)  A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in … Continued

Research Study: Meditation

Research Study: Meditation

Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you … Continued

New Treatment Shows No Benefit for Clear Cell Carcinoma     

New Treatment Shows No Benefit for Clear Cell Carcinoma     

(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. … Continued

Study Finds Many Ovarian Cancer Patients Going Untreated

Study Finds Many Ovarian Cancer Patients Going Untreated

(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and … Continued

Listen Now: Research Updates from 2016’s Top Medical Meetings

Listen Now: Research Updates from 2016’s Top Medical Meetings

Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well … Continued

The Effect of Oral Contraceptives on Ovarian Cancer

The Effect of Oral Contraceptives on Ovarian Cancer

(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention. The study, which analyzed data from 21 studies with 5, 584 cases of ovarian cancer, concluded that OC reduced the risk of a variety of invasive ovarian cancers. The risk of developing … Continued

June 2016 ASCO Highlights

June 2016 ASCO Highlights

Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meetingby Susan Leighton, Ovarian Cancer Survivor and Research Advocate   Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded.  No longer do we hear the one size fits … Continued

Capital Ovarian Cancer Organization

Capital Ovarian Cancer Organization

The Capital Ovarian Cancer Organization (C.O.C.O.) was founded in August of 2007, in memory Debi Furnish, who died from ovarian cancer in 2005. Around the same time, another woman from Frankfort, Ellen Liebman, died from the disease.  Debi’s sister, Beverly Van Houten, and her friend, Jerri Robinson, decided they needed to raise awareness of the … Continued

Highlights from the June 2016 American Society of Clinical ...

Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

(June 20, 2016) Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting by Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded. No longer do we hear … Continued

OCRFA Research Sheds Light on Role of STAT3 in Ovarian Cancer

OCRFA Research Sheds Light on Role of STAT3 in Ovarian Cancer

(June 17, 2016) An OCRFA funded study recently published in Oncogene investigated the role that protein STAT3 plays in the activation and metastasis of ovarian cancer cells. Many women with ovarian cancer develop fluid in the abdomen, which contains cancer cells. Those cells, coupled with a high activation of STAT3, can spread to other areas … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.